New Treatment for NF1 Malignant Cancer

Young adults with Neurofibromatosis type I (NF1) are at risk for developing a rare type of sarcoma called a malignant peripheral nerve sheath tumor (MPNST).  These deadly cancers can be exceedingly difficult to treat, and the only known curative therapy requires complete resection of the tumor.  Since many of these cancers cannot be completely removed, […]

Gutmann Awarded International Fellowships

David H. Gutmann, MD, PhD, has been awarded the Alexander von Humboldt Professorship, Germany’s highest academic award for researchers outside the country, and has been named an Einstein Visiting Fellow by the Berlin Institute of Health. Dr. Gutmann will be working with the Max Delbrück Center for Molecular Medicine, co-leading a team to investigate the relationship between a type of brain cell, known as microglia, and neurological diseases, including brain tumors and autism.

Fourth International NF1 Autism Workshop Held in Washington DC

Children with Neurofibromatosis type 1 (NF1) have a higher risk of developing autism spectrum disorder than their unaffected peers. Based on these clinical observations, an international consortium was established in 2015. This International NF1 Autism Consortium Team (INFACT) worked together over the ensuing years to leverage the collective experience of six major medical centers with […]

Patient Spotlight: Trevor Vail

My little brother Trevor is 13 and has NF1. In fact, so does his dad, Kenny and other members of the family. No one in the family had any idea that they had NF1 until one day when Trevor was around two years old, my mom, Kenny, and Trevor were at a restaurant. A lady […]